NEW YORK (GenomeWeb News) — Inpharmatica today said that Schering AG has obtained a multi-year, multi-user license to its Kinase SARfari knowledge base.
The product covers the biology and chemistry of the major group of successful targets in drug discovery, and Schering will use it as part of its drug-discovery process in the field of protein kinases, Inpharmatica said.
Financial terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Sponsored by

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.